Clinical Trial Update: Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and cost effectiveness of pharmacokinetic dosing in severe Haemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Snippet

Sponsor: Hampshire Hospitals NHS Foundation Trust | Conditions: Severe Haemophilia A | Phase 4 | Status: COMPLETED